Nag A, Khetan V
Indian J Ophthalmol. 2024; 72(6):778-788.
PMID: 38804799
PMC: 11232864.
DOI: 10.4103/IJO.IJO_2414_23.
Meel R, Kulkarni S, Singh L, Chinnaswamy G, Radhakrishnan V, Madan R
Indian J Pediatr. 2024; 91(11):1166-1176.
PMID: 38609685
DOI: 10.1007/s12098-024-05095-0.
Byroju V, Nadukkandy A, Cordani M, Kumar L
Cell Commun Signal. 2023; 21(1):226.
PMID: 37667345
PMC: 10478474.
DOI: 10.1186/s12964-023-01223-z.
Vogele D, Sollmann N, Beck A, Haggenmuller B, Schmidt S, Schmitz B
Diagnostics (Basel). 2022; 12(10).
PMID: 36292065
PMC: 9600631.
DOI: 10.3390/diagnostics12102376.
Schluter S, Bornfeld N, Valiyev E, Fluhs D, Stuschke M, Bechrakis N
Ocul Oncol Pathol. 2022; 8(1):64-70.
PMID: 35356603
PMC: 8914268.
DOI: 10.1159/000520952.
Tumor Environment of Retinoblastoma, Intraocular Cancer.
Jo D, Kim J, Kim J
Adv Exp Med Biol. 2021; 1296:349-358.
PMID: 34185303
DOI: 10.1007/978-3-030-59038-3_21.
Effect of Intravenous Chemotherapy Regimen on Globe Salvage Success Rates for Retinoblastoma Based on Disease Class-A Meta-Analysis.
Daniels A, Patel S, Milam R, Kohanim S, Friedman D, Koyama T
Cancers (Basel). 2021; 13(9).
PMID: 34066325
PMC: 8125212.
DOI: 10.3390/cancers13092216.
Intravenous Chemotherapy for Retinoblastoma in the Era of Intravitreal Chemotherapy: A Systematic Review.
Raval V, Bowen R, Soto H, Singh A
Ocul Oncol Pathol. 2021; 7(2):142-148.
PMID: 33981697
PMC: 8077434.
DOI: 10.1159/000510506.
Globe salvage treatment in group D and group E retinoblastoma.
Hussain A, Rahul R, Carlos R, Francisco Z, Maria G, Flavia P
Rom J Ophthalmol. 2021; 65(1):20-24.
PMID: 33817429
PMC: 7995513.
DOI: 10.22336/rjo.2021.5.
The Predictive Value of the Eighth Edition of the Clinical TNM Staging System for the Likelihood of Eye Salvage for Intraocular Retinoblastoma by Systemic Chemotherapy and Focal Therapy.
Yousef Y, Mohammad M, Mehyar M, Sultan I, Al-Hussaini M, Alhourani J
J Pediatr Hematol Oncol. 2021; 43(6):e841-e847.
PMID: 33769386
PMC: 8373642.
DOI: 10.1097/MPH.0000000000002144.
Intra-arterial Chemotherapy as Primary Treatment for Cavitary Retinoblastoma: Excellent Response in Eight Tumors.
Zheng Y, Froehler M, Friedman D, Daniels A
Ophthalmol Retina. 2020; 5(5):479-485.
PMID: 32853834
PMC: 7906432.
DOI: 10.1016/j.oret.2020.08.011.
Retinoblastoma: Etiology, Modeling, and Treatment.
Kaewkhaw R, Rojanaporn D
Cancers (Basel). 2020; 12(8).
PMID: 32824373
PMC: 7465685.
DOI: 10.3390/cancers12082304.
[Retinoblastoma].
Bornfeld N, Lohmann D, Bechrakis N, Biewald E
Ophthalmologe. 2020; 117(4):389-402.
PMID: 32206913
DOI: 10.1007/s00347-020-01081-x.
Survival and ocular preservation in a long-term cohort of Japanese patients with retinoblastoma.
Ueda T, Koga Y, Yoshikawa H, Tanabe M, Yamana K, Oba U
BMC Pediatr. 2020; 20(1):37.
PMID: 31992242
PMC: 6986142.
DOI: 10.1186/s12887-020-1923-7.
Metastases and death rates after primary enucleation of unilateral retinoblastoma in the USA 2007-2017.
Lu J, Francis J, Dunkel I, Shields C, Yu M, Berry J
Br J Ophthalmol. 2018; 103(9):1272-1277.
PMID: 30361279
PMC: 6483895.
DOI: 10.1136/bjophthalmol-2018-312915.
Comparison between intravenous chemotherapy and intra-arterial chemotherapy for retinoblastoma: a meta-analysis.
Chen Q, Zhang B, Dong Y, Mo X, Zhang L, Huang W
BMC Cancer. 2018; 18(1):486.
PMID: 29703164
PMC: 5924469.
DOI: 10.1186/s12885-018-4406-6.
The management of retinoblastoma.
Fabian I, Onadim Z, Karaa E, Duncan C, Chowdhury T, Scheimberg I
Oncogene. 2018; 37(12):1551-1560.
PMID: 29321667
DOI: 10.1038/s41388-017-0050-x.
Retinoblastoma, the visible CNS tumor: A review.
Dimaras H, Corson T
J Neurosci Res. 2018; 97(1):29-44.
PMID: 29314142
PMC: 6034991.
DOI: 10.1002/jnr.24213.
Classification of retinoblastoma: Evolution with time and the need for uniformity.
Maitray A, Khetan V
Oman J Ophthalmol. 2017; 10(3):133-134.
PMID: 29118485
PMC: 5657152.
DOI: 10.4103/0974-620X.216017.
Neonatal Retinoblastoma.
Kivela T, Hadjistilianou T
Asia Pac J Oncol Nurs. 2017; 4(3):197-204.
PMID: 28695165
PMC: 5473090.
DOI: 10.4103/apjon.apjon_18_17.
